Bruker (BRKR) Scheduled to Post Quarterly Earnings on Tuesday

Bruker (NASDAQ:BRKR - Get Free Report) will be announcing its earnings results before the market opens on Tuesday, November 5th. Analysts expect the company to announce earnings of $0.61 per share for the quarter. Bruker has set its FY24 guidance at $2.59-2.64 EPS and its FY 2024 guidance at 2.590-2.640 EPS.Individual that wish to listen to the company's earnings conference call can do so using this link.

Bruker (NASDAQ:BRKR - Get Free Report) last posted its quarterly earnings data on Tuesday, August 6th. The medical research company reported $0.52 EPS for the quarter, meeting the consensus estimate of $0.52. Bruker had a return on equity of 24.92% and a net margin of 11.29%. The firm had revenue of $800.70 million during the quarter, compared to the consensus estimate of $799.44 million. During the same period in the prior year, the company earned $0.50 EPS. The firm's revenue was up 17.4% compared to the same quarter last year. On average, analysts expect Bruker to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Bruker Price Performance

BRKR traded down $0.41 on Tuesday, hitting $58.05. 1,060,309 shares of the company's stock were exchanged, compared to its average volume of 1,048,238. Bruker has a fifty-two week low of $53.79 and a fifty-two week high of $94.86. The stock has a market cap of $8.44 billion, a price-to-earnings ratio of 21.11, a P/E/G ratio of 2.52 and a beta of 1.18. The firm has a 50-day moving average price of $64.60 and a 200-day moving average price of $67.36. The company has a current ratio of 1.65, a quick ratio of 0.75 and a debt-to-equity ratio of 1.18.

Bruker Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, September 16th. Investors of record on Monday, September 2nd were paid a dividend of $0.05 per share. The ex-dividend date was Friday, August 30th. This represents a $0.20 annualized dividend and a yield of 0.34%. Bruker's dividend payout ratio is presently 7.27%.

Analyst Ratings Changes

Several research analysts have recently weighed in on the company. Wolfe Research cut Bruker from an "outperform" rating to a "peer perform" rating in a report on Monday, September 30th. Barclays began coverage on Bruker in a research note on Tuesday, October 15th. They set an "overweight" rating and a $75.00 price objective on the stock. TD Cowen cut their target price on Bruker from $74.00 to $72.00 and set a "hold" rating for the company in a research note on Wednesday, August 7th. The Goldman Sachs Group lowered their price target on shares of Bruker from $72.00 to $60.00 and set a "sell" rating on the stock in a research report on Tuesday, July 9th. Finally, Wells Fargo & Company initiated coverage on shares of Bruker in a report on Tuesday, August 27th. They issued an "overweight" rating and a $78.00 price objective for the company. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and seven have given a buy rating to the company. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $80.82.

Bruker Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.